Actionable insights straight to your inbox

logo_equities.svg

GlaxoSmithKline’s Trademark Application for “COMMITMENT TO ACCESS” Filed

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “COMMITMENT TO ACCESS” by Christopher M Hanes, representing GlaxoSmithKline. This application was made available to the public on June 27, 2014 (see also Trademarks).
The serial number for this application is 78130796.
The international trademark goods and services class code for this trademark application is 044.
As submitted by the applicant, this trademark application relates to the following goods and services: Charitable services, namely providing indigent patients with prescription drugs together with information about pharmaceutical access and reimbursement programs.
The owner/registrar information for this application is: Christopher M Hanes, GlaxoSmithKline, LGTM, C.3157.3D, Five Moore Drive, Research Triangle Park NC 27709.
Keywords for this news article include: Pharmaceutical Companies, Trademarks, GlaxoSmithKline.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Many of us economy-watchers have been expecting recession, though with significant differences on odds and timing. Regardless, recent banking developments just made recession more likely and may have accelerated its onset.
Many people think of position size in terms of how many shares they own of a particular stock. But it’s much smarter to think of it in terms of what percentage of your total capital is in a particular stock.